期刊文献+

慢性肾脏病肌少症的发病机制研究进展 被引量:5

Research progress on the pathogenesis of Sarcopenia in chronic kidney disease
下载PDF
导出
摘要 肌少症是一种进行性的以骨骼肌质量下降、力量减弱、功能降低为主要特点的临床综合征。老年人群中该病发病率高,随着肾功能减退,肌少症发病率进一步升高。肌少症不仅增加慢性肾脏病病人的经济负担,还严重影响病人生活质量和增加死亡率。本文主要就慢性肾脏病肌少症的发病机制做一综述,以期提高医务工作者对慢性肾脏病肌少症的认识。 Sarcopenia is a progressive syndrome mainly characterized by a decrease in skeletal muscle mass,strength and function.The incidence rate is high in the elderly population,and the incidence is further increased with renal dysfunction.Sarcopenia not only increases the financial burden of patients with chronic kidney disease,but also seriously affects the patients'quality of life and increases mortality.In order to improve medical workers'understanding of sarcopenia in chronic kidney disease,this article mainly reviews the pathogenesis of the disease.
作者 熊琳(综述) 欧三桃(审校) XIONG Lin;OU San-tao(Department of Nephrology,the Affiliated Hospital of Southwest Medical University;Sichuan Center for Clinical Medicine of Kidney Diseases,Luzhou 646000,Sichuan,China)
出处 《肠外与肠内营养》 CSCD 北大核心 2019年第5期306-310,共5页 Parenteral & Enteral Nutrition
关键词 慢性肾脏病 肌少症 发病机制 治疗 Chronic kidney disease Sarcopenia Pathogenesis Treatment
  • 相关文献

参考文献2

二级参考文献15

  • 1Feldt-Rasmussen B,Lange M,Sulowicz W.Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition,Quality of Life,and Cardiovascular Risk.J Am Soc Nephrol,2007,18:2161-2171.
  • 2Ayala E R,Pecoits-Filho R,Heimburger O,et al.Associations between plasma ghrelin levels and body composition in end-stage renal disease:a longitudinal studyd.Nephrol Dial Transplant,2004,19:421-426.
  • 3Ericsson F,Divino Filho J C,Lindgren B F.Growth Hormone Treatment in Hemodialysis Patients A Randomized,Double-blind,Placebo-controlled Study.Scandinavian Journal of Urology and Nephrology,2004,38:340-347.
  • 4Mahesh S,Kaskel F.Growth hormone axis in chronic kidney disease.Pediatr Nephrol,2008,23:41-48.
  • 5Stoli c R,Trajkovic G.Protein-energetic malnutrition as a predictor of mortality in patients on haemodialysis.Med Pregl,2009,62:573-577.
  • 6Recco MV,Frankenfield DL,Hopson SD,et al.Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis.Annals of Internal Medicine,2006,145:512-519.
  • 7Garibotto G,Russo R,Sofia A,et al.Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases.Kidney International,2008,74:937-945.
  • 8Kopple JD,Brunori G,Leiserowitz M,et al.Growth hormone induces anabolism in malnourished maintenance haemodialysis patients.Nephrol Dial Transplant,2005,20:952-958.
  • 9Joel D,Kopple,Alfred K,Cheung.Opportunitytm:A Randomized Clinical Trial of Growth Hormone on Outcome in Hemedialysis Patients.Clin J Am Soc Nephrol,2008,3:1741-1751.
  • 10Pupim LB,Flakoll PJ,Yu C,et al.Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients.Am J Clin Nutr,2005,82:1235-1243.

共引文献35

同被引文献36

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部